본문 바로가기

A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
PSYCHOPHARMACOLOGY201(4) · pp.611 · 2009
피인용
Web of Science 79
JCR IF
JCR 2008 3.676
ISSN
0033-3158

저자

  1. 김성곤제1저자부산대학교, 의과대학, 의학과, KO
  2. Kim, Cheol-Min병원, KO
  3. Choi, Sam-Wook울산대학교, Coll Med, Dept Psychiat, KO
  4. Jae, Young-Myo봉생병원, Dept Psychiat, KO
  5. Lee, Hae-Gook가톨릭대학교, Coll Med, Dept Psychiat, KO
  6. Son, Bong-Ki한림대학교, Med Ctr, Chuncheon Sacred Heart Hosp, KO
  7. Kim, Jeong-Gee메리놀병원, Dept Psychiat, KO
  8. Choi, Young-Sung성안드레아 신경정신병원, Icheon, KO
  9. Kim, Han-Oh계요병원, Keyo Med Fdn, KO
  10. Kim, Seong-Yeon동아대학교, Div Management Informat Sci, KO
  11. Oslin, David W.Univ Penn, US

초록

Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (OPRM1) and response to naltrexone treatment. The Asp40 variant genotype previously shown to be associated with naltrexone treatment response is known to be relatively common among Koreans. This study was conducted to prospectively investigate the relationship between genotype and response to open-label naltrexone treatment in Korean alcohol-dependent subjects. Sixty-three alcohol-dependent subjects were prescribed naltrexone for 12 weeks in combination with cognitive behavioral therapy. Thirty-two subjects were adherent, taking the medication at least 80% of the treatment days [16 Asn40 (A/A) patients and 16 Asp40 variant (A/G or G/G) patients]. Subjects adherent to naltrexone treatment with one or two copies of the Asp40 allele took a significantly longer time than the Asn40 group to relapse (p=0.014). Although not significant, the Asn40 group treated with naltrexone had a 10.6 times greater relapse rate than the Asp40 variant group. There was no significant difference between the Asn40 group and the Asp40 variant group treated with naltrexone in rates of abstinence. These results demonstrating a higher therapeutic effect of naltrexone in Korean alcohol-dependent individuals with the Asp40 variant genotype than the Asn40 genotype are consistent with previous study results in individuals of European descent. This is the first study to examine the pharmacogenetics treatment response to naltrexone in non-European subjects.

식별자

WoS UID
000261263800015